Sponsor or institution

Clinical trials and research at TG Therapeutics, Inc.

• 9Clinical trials
• 10Countries

Newest trials

All recruiting trials (9)

• Ublituximab in people with schizophrenia

  This study tests whether ublituximab can help reduce symptoms in adults with treatment‑resistant schizophrenia who are already taking standard antipsychotic therapy.

  Recruiting at 2 sites Phase 2 TG Therapeutics, Inc. · Little Rock, Arkansas and 1 other locations · NCT07680946

• Ublituximab maintenance after efgartigimod response in myasthenia gravis

  This study tests whether giving ublituximab as maintenance after a positive response to efgartigimod helps adults with myasthenia gravis.

  Recruiting at 7 sites Phase 2 TG Therapeutics, Inc. · Colorado Springs, Colorado and 6 other locations · NCT07673744

• Long-term safety follow-up after Azer-Cel in B-cell autoimmune disorders

  This observational study follows people who already received Azer-Cel to see if any long-term safety events occur over up to 15 years.

  Recruiting TG Therapeutics, Inc. · Morrisville, North Carolina · NCT07577583

• Ublituximab in MS: how injection site and delivery method affect absorption

  This study tests how different SC injection sites and a prefilled pen delivery compare in how ublituximab behaves in the body for people with relapsing MS.

  Recruiting at 44 sites Phase 2 TG Therapeutics, Inc. · Bihać and 43 other locations · NCT07503873

• Ublituximab in Pediatric Relapsing MS: See if a B-cell therapy works in kids

  This study tests whether ublituximab can work in children and teens with relapsing MS and compares it to fingolimod in eligible participants.

  Recruiting at 5 sites Phase 2/3 TG Therapeutics, Inc. · Salt Lake City, Utah and 5 other locations · NCT07220252

• Assessing the safety and effectiveness of Azer-cel for autoimmune disorders

  This study is testing a new treatment called Azer-cel to see if it is safe and effective for people with certain autoimmune disorders, especially those with progressive multiple sclerosis.

  Recruiting at 8 sites Phase 1 TG Therapeutics, Inc. · La Jolla, California and 7 other locations · NCT06680037

• Evaluating the effects of BRIUMVI® on pregnancy outcomes in women with Multiple Sclerosis

  This study is trying to see if using BRIUMVI® during pregnancy affects the health of babies born to women with Multiple Sclerosis compared to those who didn’t use the medication.

  Recruiting TG Therapeutics, Inc. · Wilmington, North Carolina · NCT06433765

• Evaluating real-world experiences of patients treated with BRIUMVI® for relapsing multiple sclerosis

  This study is looking to see how well BRIUMVI® works and what side effects it has for people with relapsing multiple sclerosis in everyday settings.

  Recruiting at 113 sites TG Therapeutics, Inc. · Birmingham, Alabama and 112 other locations · NCT06433752

• Evaluating a modified treatment regimen of ublituximab for relapsing multiple sclerosis

  This study is testing a new way to use ublituximab to see if it can help people with relapsing multiple sclerosis feel better and stay safe.

  Recruiting at 49 sites Phase 3 TG Therapeutics, Inc. · Birmingham, Alabama and 50 other locations · NCT05877963

Quick answers

How many clinical trials run by TG Therapeutics, Inc. are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 10 countries. The most sites are in United States (8 trials), Poland (3 trials), Slovakia (1 trial), Puerto Rico (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 1: 1, Phase 2/3: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →